NR 566 / NR566 Advanced Pharmacology Care of the Family Midterm Review Quiz bank | LATEST, Questions and Verified Answers | Chamberlain College

Document Content and Description Below

When blood glucose levels are difficult to control in type 2 diabetes some form of insulin may be added to the treatment regimen to control blood glucose and limit complication risks. Which of the fol... lowing statements is accurate based on research? A. Premixed insulin analogues are better at lowering HbA1C and have less risk for hypoglycemia. B. Premixed insulin analogues and the newer premixed insulins are associated with more weight gain than the oral antidiabetic agents. C. Newer premixed insulins are better at lowering HbA1C and postprandial glucose levels than long-acting insulins. D. Patients who are not controlled on oral agents and have postprandial hyperglycemia can have neutral protamine Hagedorn insulin added at bedtime. 2. Metformin is a primary choice of drug to treat hyperglycemia in type 2 diabetes because it: A. Substitutes for insulin usually secreted by the pancreas B. Decreases glycogenolysis by the liver C. Increases the release of insulin from beta cells D. Decreases peripheral glucose utilization 3. Prior to prescribing metformin, the provider should: A. Draw a serum creatinine to assess renal function B. Try the patient on insulin C. Tell the patient to increase iodine intake D. Have the patient stop taking any sulfonylurea to avoid dangerous drug interactions 4. The action of “gliptins” is different from other antidiabetic agents because they: A. Have a low risk for hypoglycemia B. Are not associated with weight gain C. Close ATP-dependent potassium channels in the beta cell D. Act on the incretin system to indirectly increase insulin production 5. Sitagliptin has been approved for: A. Monotherapy in once-daily doses B. Combination therapy with metformin C. Both 1 and 2 D. Neither 1 nor 2 [Show More]

Last updated: 1 year ago

Preview 1 out of 51 pages